Diagnostic and Prognostic Value of 18F-FDG PET/CT in Male Breast Cancer: Results From a Bicentric Population

E-ISSN： 1874-4729|9|2|169-177

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.9, Iss.2, 2016-08, pp. : 169-177

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk stratification in patients with advanced-stage breast cancer by pretreatment [18F]FDG PET/CT

Cancer, Vol. 121, Iss. 22, 2015-11 ,pp. : 3965-3974

Blackwell Publishing

Access to resources Recommend Favorite

Clinical Applications of 18F-FDG PET/CT in Monitoring Anti-cancer Therapies

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 7, 2013-10 ,pp. : 658-668

Bentham Science Publishers

Access to resources Recommend Favorite

18F-FDG-PET/CT in Patients Affected by Differentiated Thyroid Carcinoma with Positive Thyroglobulin Level and Negative 131I Whole Body Scan. It's Value Confirmed by a Bicentric Experience

Current Radiopharmaceuticals, Vol. 9, Iss. 3, 2016-12 ,pp. : 228-234

Bentham Science Publishers

Access to resources Recommend Favorite

18F-FAZA PET/CT in the Preoperative Evaluation of NSCLC: Comparison with 18F-FDG and Immunohistochemistry

Current Radiopharmaceuticals, Vol. 11, Iss. 1, 2018-04 ,pp. : 50-57

Bentham Science Publishers

Access to resources Recommend Favorite

Diagnostic agent (18 F-FDG): therapeutic potential in breast cancer?

Inpharma, Vol. 1, Iss. 1404, 2003-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite